Other studies of DLBCL have shown that high CD68+/CD163+ M2 TAM or CD163+ M2-type macrophage counts at diagnosis were significantly correlated with unfavorable clinical prognosis [8, 9]. The gene discussed is CD163; the disease is diffuse large B-cell lymphoma.